Pharmaceutical Executive: February 2024

Click the title above for a link to open the Pharmaceutical Executive February 2024 issue in an interactive PDF format.

Harpreet Gill, vice president of real-world solutions - project management at ICON, discussesthe progress and challenges in advancing data-driven tools and approaches in decentralized clinical trials, where ongoing education remains paramount.

A strategic formulation for separate IDN market spaces.

Recognition of the business case for ESG in pharma is soaring.

Embracing business imperatives such as operational efficiency and a focus on a patient-centric approach can help pharma leaders provide a stable foundation amid lingering uncertainty.

Projecting the viability of the JPM jumpstart over the long haul.